Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment
Novotná, Eva, Büküm, Neslihan, Hofman, Jakub, Flaxová, Michaela, Kouklíková, Etela, Louvarová, Dagmar, Wsól, VladimírLanguage:
english
Journal:
Biochemical Pharmacology
DOI:
10.1016/j.bcp.2018.08.001
Date:
August, 2018
File:
PDF, 1.82 MB
english, 2018